CIK 0001217234 · Large accelerated filer
CareDx, Inc.
Sign in to watch- Ticker
- CDNA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943316839
- Phone
- 415-287-2300
- Business address
- 8000 MARINA BLVD, 4TH FLOOR, BRISBANE, CA, 94005
- Former names
- XDx, Inc., EXPRESSION DIAGNOSTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,154,003
- in 2 filings, $5.2M under 10b5-1 plans
Net −$5,154,003. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −2,996 | $80.47 | $241K | 97,704 |
| 2026-11-10 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −200 | $81.05 | $16K | 97,504 |
| 2026-11-10 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −900 | $83.33 | $75K | 96,604 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −28,256 | $76.55 | $2.2M | 232,852 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −12,380 | $77.42 | $958K | 220,472 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −6,897 | $78.59 | $542K | 213,575 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −7,415 | $79.49 | $589K | 206,160 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −3,403 | $80.38 | $274K | 202,757 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −2,710 | $81.40 | $221K | 200,047 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −300 | $82.08 | $25K | 199,747 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −600 | $83.60 | $50K | 199,147 |
| 2026-08-05 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −2,188 | $46.15 | $101K | 106,575 |
| 2026-08-05 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −500 | $46.75 | $23K | 106,075 |
| 2026-08-05 | Bickerstaff George Director | Sale | −20,000 | $46.29 | $926K | 134,061 |
| 2026-08-04 | Goldberg Michael Director | Sale | −44,700 | $47.06 | $2.1M | 61,738 |
| 2026-08-04 | COURNOYER CHRISTINE Director | Sale 10b5-1 | −16,000 | $46.94 | $751K | 42,943 |
| 2026-07-16 | Valantine Hannah Director | Sale 10b5-1 | −28,679 | $36.14 | $1.0M | 36,786 |
| 2026-07-16 | Valantine Hannah Director | Sale 10b5-1 | −100 | $36.55 | $4K | 36,686 |
| 2026-07-16 | Hanna John Walter JR President and CEO | Sale 10b5-1 | −50,000 | $36.11 | $1.8M | 721,448 |
| 2026-07-16 | Hanna John Walter JR President and CEO | Sale 10b5-1 | −68,000 | $39.01 | $2.7M | 653,448 |
Page 1 of 4 · 76 trades